Earning Plays

[3xBuBu]

Ariad Pharmaceuticals Q4 Loss Widens
Ariad Pharmaceuticals Inc. (ARIA | news | PowerRating | PR Charts ) reported a fourth quarter net loss of $15.7 million or $0.23 loss per share, compared to a net loss of $14.4 million or $0.22 loss per share, for the same quarter of last year.

Total license revenue for the quarter was $1.60 million, up from $208 thousand in the year ago quarter.

Analysts surveyed by First Call/Thomson Financial expected the company to report a loss of $0.21 per share on revenues of $3.29 million in the fourth quarter.

For fiscal 2008, the Company estimates cash used in operations of $41 million to $44 million.

For 2008, the company estimates a net loss of $81 million to $84 million, an increase over its net loss for fiscal year 2007 of $58.5 million.
http://www.tradingmarkets.com/.site/news/BREAKING%20NEWS/1076954/